Kyntra Bio (KYNB) EBIT (QoQ) (2014 - 2026)
Kyntra Bio (KYNB) EBIT (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.24 Bn | 131.39 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.01 Bn | 78.02 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.61 Bn | 60.42 Bn | 1.37 Bn |
| 4 | Moderna | 56.92 Bn | 51.78 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.77 Bn | 9.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Kyntra Bio | 29.96 Mn | 29.96 Mn | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27.18% |
| Mar 31, 2026 | -2.26% |
| Dec 31, 2025 | -149.71% |
| Sep 30, 2025 | 55.10% |
| Jun 30, 2025 | 19.22% |
| Mar 31, 2025 | -109.17% |
| Dec 31, 2024 | 85.04% |
| Sep 30, 2024 | -2.77% |
| Jun 30, 2024 | 5.64% |
| Mar 31, 2024 | 48.28% |
| Dec 31, 2023 | -49.81% |
| Sep 30, 2023 | 27.90% |
| Jun 30, 2023 | -15.71% |
| Mar 31, 2023 | -15.02% |
| Dec 31, 2022 | 29.37% |
| Sep 30, 2022 | -19.73% |
| Jun 30, 2022 | -24.18% |
| Mar 31, 2022 | 53.42% |
| Dec 31, 2021 | -365.31% |
| Sep 30, 2021 | 138.09% |